|
|
| Research article summary (published 30 Dec 2006): |
A critical appraisal of a randomized controlled trial: Willson et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury (JAMA 2005, 293: 470-476).
Full Abstract
OBJECTIVE:
To evaluate the use of exogenous surfactant in pediatric acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) in decreasing the duration of respiratory failure.
DESIGN:
A critical appraisal of a randomized controlled trial.
FINDINGS:
This was a multiple-center, randomized, double-blinded, placebo-controlled trial evaluating the effect of calfactant via endotracheal tube in pediatric ALI/ARDS. The primary outcome was duration of respiratory failure measured by ventilator-free days at 28 days. Secondary outcomes included hospital course, adverse events, and failure of conventional mechanical ventilation (use of high-frequency oscillatory ventilation, inhaled nitric oxide, or extracorporeal membrane oxygenation). One hundred and fifty-two patients were enrolled and randomized with strict inclusion and exclusion criteria. Aside from the experimental interventions, the treatment and placebo groups were similar at baseline. Ventilator management guidelines were defined a priori. No significant difference in ventilator-free days was found, although the treatment group had a greater improvement in oxygenation. Mortality rate was significantly greater in the placebo group (relative risk, 1.9; 95% confidence interval, 1.1-3.2). However, when controlled for immunocompromised status, the statistical significance is lost. Subgroup analysis of infants showed a greater effect on mortality (relative risk, 3.3; 95% confidence interval, 1.1-10.5) and a significant difference in ventilator-free days (15.2 days vs. 7.0 days, p = .01) for the placebo group. No other differences in measured outcomes were seen. The treatment group had an increased rate of hypotension and transient hypoxia but not of airleaks or nosocomial pneumonias.
CONCLUSIONS:
This is a well-designed study with an appropriate intention-to-treat analysis, but it is underpowered, making it difficult to identify which patients with pediatric ALI/ARDS might benefit from calfactant. Given the uncertainty of the benefits, calfactant cannot be routinely recommended in pediatric ALI/ARDS.
Learn Faster Today Improve your study skills
Author information
Author/s: Czaja, Angela S (AS);
Affiliation: Children's Hospital and Regional Medical Center, University of Washington, Department of Pediatric Critical Care, Seattle, WA, USA.
Journal and publication information
Publication Type: Comment; Journal Article
Journal: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies (Pediatr Crit Care Med), published in United States. (Language: eng)
Reference: 2007-Jan; vol 8 (issue 1) : pp 50-3
Dates: Created 2007/01/25; Completed 2007/04/12; Revised 2007/04/20;
PMID: 17251882, status: PubMed-not-MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
CommentOn: JAMA. 2005 Jan 26;293(4):470-6. (PMID: 15671432)
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
No MeSH Headings found.
The article may not be MeSH Indexed as yet.
Related articles
This article has not been indexed for related articles as yet, however you can still use the live related article search links below.
See a large map of 100+ related articles.